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Table 1.
Descriptive statistics for overall sample as well as divided by sex assigned at birth. Gender differences were 




[N (%)] or [M±SD]
(N = 59)
Birth assigned males
[N (%)] or [M±SD]
(N = 59)
Total sample
[N (%)] or [M±SD]
(N = 118)
Mean age (SD)* 22.53 ± 8.04 33.37 ± 14.90 27.95 ± 13.11
Employment status
    Unemployed 8 (13.6) 4 (6.8) 12 (10.2)
    Employed 11 (18.6) 21 (35.6) 32 (27.1)
    Student 25 (42.4) 14 (23.7) 39 (33.1)
    Volunteer Work 0 (0) 1 (1.7) 1 (0.8)
    Disabled 1 (1.7) 1 (1.7) 2 (1.7)
    Retired 0 (0) 2 (3.4) 2 (1.7)
    No answer 14 (23.7) 16 (27.1) 30 (25.4)
Civil status*
    Single 84 (71.2) 37 (62.7) 47 (79.7)
    Married /  10 (8.5) 9 (12.8) 1 (1.7)
    Civil partnership 3 (2.5) 0 (0) 3 (5.1)
    Divorced 1 (0.8) 8 (13.6) 1 (1.7)
    Widowed 1 (0.8) 1 (1.7) 0 (0)
    In a relationship 1 (0.8) 0 (0) 1 (1.7)
    Other 1 (0.8) 0 (0) 1 (1.7)
    No answer 9 (7.6) 4 (6.8) 5 (6.6)
*p<0.05
Confidence interval = 95%
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Table 2.






T0 41 (34.7) 77 (65.3)
T1 38 (32.2) 80 (67.8)
Assigned Females at Birth (AFAB) (n=59)
T0 22 (37.3) 37 (62.7)
T1 25 (42.4) 34 (57.6)
Assigned Males at Birth (AMAB) (n=59)
T0 19 (32.2) 40 (67.8)
T1 13 (22.0) 46 (78.0)
Confidence interval = 95%
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Table 3. 
Paired samples t-test examining change for total sample in total AQ-short total and anxiety scores from T0 to 
T1, for the overall sample as well as split by assigned gender at birth.
 
T0 (M±SD) T1 (M±SD) t (df) Effect size 
(d)
p
AQ-Short - Total 
(n=118)
64.78 ± 12.26 65.55 ± 12.51 -.876 (117) 0.062 .388
Anxiety (n=116) 8.00 ± 4.23 8.05 ± 3.76 -.125 (115) 0.012 .9
Assigned Females at Birth (AFAB)
AQ-Short - Total (n=59) 66.54 ± 11.81 68.41 ± 12.60 -1.448 (58) 0.153 .153
Anxiety (n=57) 8.39 ± 4.33 8.49 ± 3.79 -.167 (56) 0.023 .868
Assigned Males at Birth (AMAB)
AQ-Short - Total (n=59) 63.02 ± 12.55 62.69 ± 11.85 .264 (58) 0.027 .793
Anxiety (n=59) 7.63 ± 4.14 7.63 ± 3.71 -.000 (58) 0.069 1
* p<0.05
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Excluded 148 participants due to:
Hormone treatment pre-assessment
Incomplete AQ-Short data at baseline
Did not consent
Excluded 174 participants due to:
Incomplete data at follow-up




Figure 1. Flow chart of exclusion of participants.
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Background: Recent research has shown that a high percentage of treatment-seeking transgender adults who were assigned 
female at birth (AFAB) reported scores above the clinical cut-off for autistic traits. It is unclear whether those scores reflect 
a stable trait or may be inflated by the high levels of anxiety typically associated with transgender people attending clinical 
services.
Aims: This longitudinal study aims to explore the impact of Cross-sex Hormone Treatment (CHT) on levels autistic traits, 
independent of changes in anxiety.
Method: Transgender adults who were assessed at a national transgender health service in the UK, who had not previously 
received CHT and who had completed the AQ-Short as a measure of autistic traits pre- and one-year post-CHT were 
included in the study (n=118). Anxiety was assessed at the same time points using the Hospital Anxiety and Depression 
Scale.
Results: AQ-Short scores remained very stable over time (ICC = 0.7; CIs 0.591-0.779) but anxiety showed little consistency 
(ICC = 0.386; CIs 0.219 to 0.531). Repeated measures ANOVA found a main effect of assigned sex with AFAB having 
higher AQ-Short scores. There was no change in AQ-Short scores and no significant interaction between assignedsex and 
change in AQ-Short scores.
Conclusion: This study confirmed that treatment seeking transgender AFAB people have higher levels of autistic traits at 
follow-up compared to AMAB transgender peopleand that these traits are stable following one year of CHT regardless of 
assigned sex. This may have clinical implications regarding the support that transgender people may require following 
medical transition.
KEYWORDS
Transgender; gender dysphoria; autistic traits; autism spectrum conditions; anxiety; cross-sex hormone treatment.
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A number of studies suggest a link between the presence of Autistic Spectrum Conditions (ASC) in children and young 
people and higher rates of gender dysphoria: a discrepancy between sex assigned at birth and gender identity (Glidden, 
Bouman, Jones, & Arcelus, 2016). To-date six studies have investigated the prevalence of autistic traits in transgender 
adults (Heylens, Aspeslagh, Dierickx, Baetens, Van Hoorde, De Cuypere & Elaut, 2018; Jones, Wheelwright, Farrell, 
Martin, Green, Di Ceglie & Baron-Cohen, 2012; Kristensen & Broome, 2015; Nobili, Glazebrook, Bouman, Glidden, 
Baron-Cohen, Allison, ... & Arcelus, 2018b; Pasterski, Gilligan, & Curtis, 2014; Vermaat, van der Miesen, de Vries, 
Steensma, Popma, Cohen-Kettenis, Kreukels; 2018), with all six using versions of the Autism Spectrum Quotient (AQ) 
(Baron-Cohen, Wheelwright, Skinner, Martin, & Clubley, 2001a). Overall, findings suggest that there is a significantly 
higher percentage of transgender Assigned Females At Birth (AFAB) scoring above the cut-off for clinically significant 
autistic traits compared to both transgender Assigned Males At Birth (AMAB) and cisgender people.
Autistic Spectrum Conditions (ASC) such as Asperger syndrome and autism are neurodevelopmental conditions 
characterised by social and communication difficulties as well as restricted interests, highly repetitive behavioural patterns, 
and sensory hyper-sensitivity (APA, 2013). It has been argued that elevated autistic traits in transgender adults might reflect 
high levels of anxiety and increased social difficulties associated with gender dysphoria and experiences associated with 
being transgender such as bullying and transphobia, rather than ASC (Turban & van Schalkwyk, 2018).
However, clinically the perception that autism and gender dysphoria are co-occurring conditions has strong support 
although the mechanisms for the association are poorly understood (Strang, Janssen, Tishelman, Leibowitz, Kenworthy, 
McGuire, ... & Anthony, 2018). The finding that transgender people AFAB people are more likely to have elevated levels of 
autistic traits compared to cisgender women (45.4% vs. 30%) (Nobili, Glazebrook & Arcelus, 2018a) could relate to 
prenatal sex differences in the brain more typical of the male brain. The Extreme Male Brain (EMB) theory argues that 
males are at higher risk of autism as a result of in-utero exposure to androgens which accentuates systemising behaviour and 
diminish the drive to empathise (Auyeung, Baron-Cohen, Chapman, Knickmeyer, Taylor & Hackett, 2009; Baron-Cohen, 
2002, 2010; Baron-Cohen, Auyeung, Nørgaard-Pedersen, Hougaard, Abdallah, Melgaard, Cohen, Chakrabarti, Ruta, & 
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Lombardo, 2015; Greenberg, Warrier, Allison, & Baron-Cohen, 2018). Additionally, the EMB theory posits that on 
average, allistic (i.e., non-autistic) females and males differ in their profiles on the psychological domains of empathising 
and systemising with females having a stronger drive to empathise than systemise than males, and vice versa (Baron-Cohen, 
2010). Past research showed that people with ASC score higher than both allistic females and males in the domains of 
intuitive physics (Baron-Cohen, Wheelwright, Scahill, Lawson & Spong, 2001b), systemizing (Baron-Cohen, Richler, 
Bisarya, Gurunathan & Wheelwright), and attention to detail (Jolliffe & Baron-Cohen, 1997), thus they are thought to be on 
the extreme end of the male brain spectrum (Baron-Cohen, 2010; Greenberg et al., 2018).High levels of prenatal androgens 
have also been suggested to be responsible for a masculinised gender identity (Hines, 2006; Knickmeyer, Baron-Cohen, 
Fane, Wheelwright, Mathews, Conway, Brook & Hines, 2006).
ASC traits tend to be stable over time (Robinson, Munir, Munafò, Hughes, McCormick, & Koenen, 2011) and much of this 
stability is attributable to genetic factors (Taylor, Gillberg, Lichtenstein, & Lundström, 2017). If self-reported ASC traits in 
transgender populations reflect stable and heritable traits, then we should expect to find strong consistency over time 
regardless of Cross-sex Hormone Treatment (CHT). In contrast, levels of anxiety are more likely to be responsive to 
external factors and in transgender populations anxiety appears to be lower in those on CHT (Bouman et al., 2016, 2017; 
Millet, Longworth & Arcelus, 2017).
Aims
This study aims to investigate the stability of autistic traits in transgender people following CHT, when controlling for the 
impact of change in anxiety levels and age. It also aims to explore the impact of assigned sex at birth and change in anxiety 
on any change in levels of autistic traits.
The present study explored the following research questions; do levels of autistic traits remain stable from pre-treatment to 
one-year post-CHT, when controlling for change in anxiety and age? If autistic traits change from baseline to follow-up, 
what is the impact of sex assigned at birth and change in anxiety on changes in levels of autistic traits? As this is an 
exploratory study and the first research longitudinally investigating the impact of CHT upon levels of autistic traits, no 
hypotheses were formulated.
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Participants were consecutive attenders at a national adult transgender healthcare service in the UK between November 
2014 and June 2018. Inclusion criteria were initiation of CHT at the clinic and completion of the AQ-Short prior to 
treatment (T0 - baseline) and at one-year post CHT (T1 - follow-up). The study focusses on those who have been on 
treatment for over 12 months as this allows for enough time for hormone treatment to produce physical, bodily changes but 
before surgical procedures have taken place, which could bias the results. Unfortunately, due to the long waiting list for 
gender affirming surgical treatment in the United Kingdom (UK), it is unlikely that people will have undergone these 
interventions before this time.
Exclusion criteria were having undergone any type of gender-affirmingtreatment prior to the first assessment at the clinic(in 
order to create a more homogeneous sample and to better control for participants’ treatment status),failure to give consent to 
participation and incomplete completion of AQ at T0. Participant with a diagnosis of ASC were not excluded from the 
study.The participant flow is shown in Figure 1.   
Insert Figure 1 here
Setting
The centre is a national transgender health service that offers gender affirming medical treatment to people living in 
England and Wales. The service offers assessment for treatment suitability, psychological support, endocrinological 
treatment and referrals for gender affirming surgeries.
Design and Procedure
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A longitudinal design was adopted for the present study with data collection pre-treatment and one-year post-CHT. 
Questionnaire packs were sent out by a research assistant one-month prior to the first assessment together with the 
information sheet and consent form. The pack consisted of socio-demographic information, as well as the AQ-Short to 
measure autistic traits and the Hospital Anxiety and Depression Scale (HADS-A) to measure anxiety levels. However, 
information regarding a diagnosis of ASC was not available.Participants who returned completed questionnaires and the 
signed consent form were included in the study. One-year post-CHT, patients were provided with a second questionnaire 
pack either face-to-face or sent by post. A research assistant checked the medical notes to determine when patients reached 
one-year post-CHT in order to identify those who were eligible to participate.
Sex assigned at birth was used as the gender descriptor to allow comparison with previous research (Nobili et al., 2018b) 
and to increase the study’s power to explore gender differences in ASC traits due to the use of a binary variable rather than a 
categorical one. Participants were therefore grouped into those assigned female at birth (AFAB) and those assigned male at 
birth (AMAB).
Ethical approval for the research was received from the NHS Ethics Committee (14/EM/0092) and by the Nottinghamshire 
Healthcare NHS Foundation Trust Research and Development Department in agreement with the Health Research Authority 
guidance (HRA, 2013).
Main Outcome Measures
Autism Spectrum Quotient Short Version – AQ-Short (Hoekstra et al., 2008)
The AQ-Short is a self-reported 28-items 4-point Likert-scale ranging from 1 ‘definitely agree’ to 4 ‘definitely disagree’. It 
is used to assess autistic traits in adult individuals with average intelligence and to indicate where a person falls in the 
autistic spectrum ranging from not-autistic to autistic (Woodbury-Smith, Robinson, Wheelwright, & Baron-Cohen, 2005). 
The measure assesses difficulties and core traits related to autism, such as attention switching, social and communication 
skills and imagination (Hoekstra et al., 2008). The AQ-Short is an abridged validated version of the well-established AQ-50 
(Baron-Cohen et al., 2001). The AQ has been used in a large population of half a million people (Ruzich, Allison, 
Chakrabarti, Smith, Musto, Ring & Baron-Cohen, 2015), confirming sex differences on average (males scoring higher than 
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females) and those working in STEM (Science, Technology, Engineering, and Maths) scoring higher on average than those 
not working in STEM. Total scores range from 28 to 112 and at clinical cut-off of ≥70, the sensitivity and specificity of the 
AQ-Short are high (.94 and .91, respectively). Cronbach’s alphas for this measure range between .77 and .86 (Hoekstra et 
al., 2008).
Anxiety subscale of the Hospital Anxiety and Depression Scale, (HADS-A) (Zigmond & Snaith, 1983)
The HADS-A is a 7-item subscale of the Hospital Anxiety and Depression scale. Respondents rate their emotions over the 
previous week on 4-point Likert-scales. Total scores range between 0 and 21. The HADS is a reliable measure in assessing 
symptoms’ caseness and severity of anxiety disorders in both clinical and general populations (Bjelland, Dahl, Haug, & 
Neckelmann, 2002) as well as in clinical transgender populations (Bouman et al., 2016, 2017; Witcomb et al., 2018). The 
measure’s specificity is 0.78, sensitivity is 0.9 and reliability is excellent with Cronbach’s alphas ranging from 0.68 to 0.93 
(Bjelland et al., 2002).
Data Analysis
Data analyses were performed using the Statistical Software Package SPSS 24 (IBM, 2016). As data regarding only a few 
variables was normally distributed, and appropriate univariate analyses,such as t-tests and Mann Whitney U tests were 
carried outdepending on the variables distribution. McNemar test was adopted to assess if the percentage of clinically 
significant autistic traits differed from pre- to post-CHT, overall as well as for both gender groups.Additionally, repeated 
measures ANOVA was used to explore change in AQ-Short scores over time and interactions between assigned sex at birth 
and change in autistic trait scores over time, with anxiety change and age included as covariates. The significance level used 
for the statistical analyses was p<0.05.
Results
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A total of 440 patients were assessed during the studied period, of whom 292 were eligible to participate. One hundred-and 
eighteen patients returned a fully completed AQ-Short questionnaire, giving a response rate of 40.4%. Responders did not 
differ from non-responders in terms of either demographic characteristics or baseline AQ-Short scores, but they were less 
anxious at baseline than non-responders (median 9 vs 8, p=0.001; z=3.225).
Of the 118 participants who completed the questionnaires at follow-up, there were the equal numbers of AFAB and AMAB 
participants (n=59, 50%). AFAB transgender participants were significantly younger (Mage=22.53±8.04) than AMAB 
transgender participants (Mage=33.37±14.9), (t=4.921, df=89.158, p<0.001) (see Table 1).
Insert Table 1 here
Change in autistic traits and in anxiety symptoms post-CHT
Over a third of participants (34.7%) scored above the cut-off (>70) indicating clinically significant autistic traits at baseline. 
Post-CHT, the proportion of participants who scored above the AQ cut-off remained stable (32.2%) and there was no 
significant change in AQ-Short scores (see Table 2 and 3).
Insert Table 2 here
Repeating the analyses for each gender group also found no significant changes in the proportion of participants scoring 
above the cut-off for AQ caseness and no significant change in AQ-Short scores. However, for AFAB transgender 
participants, the percentage of people with clinically significant autistic traits rose from 37.3% to 42.4% and for AMAB 
transgender participants it fell from 32.2% to 22%. Thus, at follow-up AFAB participants were significantly more likely to 
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score above the cut-off for clinically significant autistic traits compared to AMAB participants (χ2=5.589; p=0.018). They 
also had significantly higher AQ-Short scores at follow-up (t=2.537; p=0.013).
There was a strong agreement between AQ-Short scores at time 0 and at time 1 (ICC = 0.696, CIs 0.591 to 0.779, p<0.001) 
for the group as a whole. Anxiety ratings had only poor agreement over time (ICC = 0.386, CIs 0.219 to 0.531, p<0.001): a 
significantly lower agreement compared to AQ-Short scores as indicated by the lack of overlap in the CIs.
A HADS-A change score was calculated with higher scores indicating increased levels of anxiety over time. The median 
HADS-A change scores was 0 with a range from –12 to 10. There were no significant changes in anxiety scores over time 
either for the whole group or when looking at AMAB and AFAB transgender participants separately (Table 3).
Insert Table 3 here
Change in AQ-Short scores controlling for age and change in anxiety
A two-way repeated measures ANOVA was conducted to assess change in AQ-Short scores after CHT, whilst controlling 
for age and change in anxiety, and to explore possible interactions between gender group and change in AQ-Short over 
time. Total AQ-Short scores pre- and post-treatment were the dependent variables. Sex assigned at birth was an independent 
factor with age and anxiety change scores entered as co-variants. The within-subjects factor was non-significant confirming 
that AQ-Short scores remained stable over time.  
There was a main effect of assigned sex at birth suggesting that AFAB transgender people have higher scores than AMAB 
transgender people independently of any other factor, [F(1,112) = 3.912, p=0.05, partial η2=0.034]. The gap in AQ-Short 
scores between genders appeared to widen after CHT but the interaction between change in AQ-Short scores and gender 
group was non-significant. Age was also unrelated to AQ-Short scores. There was no main effect for change in anxiety, but 
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there was a strong significant interaction with greater increase in anxiety associated with greater increase in AQ-Short 
scores over time [F(1,112)=23.338,  P<0.001. η2=0.172].
Discussion
In the group as a whole, autistic traits, as measured by the AQ-Short, remained stable following gender affirming hormone 
treatment: neither the AQ-Short scores nor the proportion of AQ-Short cases changed significantly over time. The stability 
of AQ-Short scores, confirmed by repeated measure ANOVA, is in conflict with previous research suggesting  the presence 
of autistic traits and social difficulties in transgender populations reflecting feelings of anxiety possibly due to having 
undergonenegative past experiences (Turban, 2018; Turban & van Schalkwyk, 2018). As found in previous research (Jones 
et al., 2012; Nobili et al., 2018b; Vermaat et al., 2018) transgender participants who had been assigned female at birth had 
higher AQ-Short scores overall.
Over a third of treatment seeking transgender individuals scored above the cut-off for clinically significant autistic traits. 
The key finding from this study is that AQ-Short scores appear to reflect stable traits rather than a state response to the 
social and psychological challenges of their transgender status. The study also found that although the difference in the 
proportion of ASC cases by sex assigned at birth was non-significant pre-CHT, post-CHT a greater proportion of 
participants who were AFAB scored above the cut-off for ASC caseness compared to AMAB participants. This could 
suggest that testosterone treatment enhances the expression of male brain characteristics. Previous research suggested that 
testosterone has an impact upon social connections as fluctuations in hormonal levels can divert people’s interests away 
from social interactions (Pennebaker, Groom, Loew, & Dabbs, 2004). Thus, there is need for more research into the 
psychological effects of cross-sex hormone treatment.
The study also found that, contrary to previous research (Colizzi, Costa & Todarello, 2014), anxiety levels did not reduce 
following CHT. In fact there was considerable variation in the profile of anxiety form pre- to post-CHT, as evidenced by the 
low ICC score in comparison to the stability in AQ-Short scores (0.39 vs 0.7) and the lack of overlap in CIs. However, 
changes in anxiety were associated with corresponding changes in levels of autistic traits suggesting that any increases in 
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levels of anxiety post-CHT may elevate the expression of autistic traits and thus increase social impairment. The association 
between the trajectory of anxiety and autistic traits is to be expected sincethe presence of a correlation between AQ and 
HADS was reported by past research on both adults (Kanai, Iwanami, Hashimoto, Tani, Yamada & Kato, 2011) and youth 
(Uljarević, Richdale, McConachie, Hedley, Cai, Merrick, Parr & Le Couteur, 2018) populations, showing thatthere is a 
significant overlap in symptomatology between anxiety and ASC (Cath, Ran, Smit, Van Balkom, & Comijs, 2008).
This study represents an important advance in the research on autism in transgender populations, as it is the first study that 
longitudinally explores the effect of cross-sex hormone treatment on autistic traits. However, there are also limitations to the 
study such as low response rate at follow-up. Participants may have also downplayed their autistic traits before their first 
assessment at the clinic for fear of not being treated. Consequently, participants may have attenuated their mental health 
symptoms concerned about not being accepted for cross-sex hormone treatment. This could indicate that the changes 
between T0 and T1 may be more significant than recorded.Additionally, poor completion of the questionnaire and an under-
representation of more anxious participants in the sample may have limited the study’s capacity to demonstrate a reduction 
in anxiety symptoms post-treatment.
Nonetheless, participants’ AQ-Short scores were representative of the wider clinical population. The AQ-Short is a self-
report tool to measure autistic traits and is not an autism diagnostic instrument, but it has a number of strengths as a valid 
and reliable measure that is widely used in clinical research.
The findings of this study can support the extreme male brain theory of autism (Baron-Cohen, 2002) as it suggests the 
presence of gender differences in the expression of autistic traits.Additionally, this theory suggests that individuals who 
were AMAB report higher percentages of ASC (Baron-Cohen, 2002) whilst the results of the present study indicate that 
AFAB transgender individuals (or possible transmen) report enhanced rates of clinically significant autistic traits. Therefore, 
these findings seem to suggest that transgender assigned females at birth may have a similar autistic profile to cisgender 
men rather than cisgender women.
Conclusion
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Autistic traits remained stable following cross-sex hormone treatment for both AMAB and AFAB transgender individuals. 
However, the apparent widening gap in the proportion of AFAB participants and AMAB participants scoring above the cut-
off for clinically significant autistic traits suggests that the pattern of response to hormone treatment may differ but this 
needs further investigation in a larger sample. It may simply reflect the fact that living as the experienced gender allows 
stronger expression of male traits.
These results highlight the need to properly support transgender people (especially AFAB transgender people) when 
transitioning, as autistic traits in this population may be at a clinically significant level for at least a third of people, and 
seems to be independent of hormone treatment. Support can be specifically tailored and delivered with online interventions 
as they might be particularly suited for this population (Perry, Strauss, & Lin, 2018).
Thus, a better understanding of the psychological impact of hormone treatment is needed in order to properly support 
transgender people through transition and to enable them to make informed decisions about gender-affirming medical 
treatment.
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